Binh Dinh Pharmaceutical & Medical Equipment JSC

As of June 30, 2026, Binh Dinh Pharmaceutical & Medical Equipment JSC carries a market capitalization of 4.91T, placing it among publicly traded companies globally. Its enterprise value stands at 4.65T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Binh Dinh Pharmaceutical & Medical Equipment JSC's next confirmed earnings release is scheduled for December 2, 2026.

As of June 30, 2026, Binh Dinh Pharmaceutical & Medical Equipment JSC has 94.49M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Binh Dinh Pharmaceutical & Medical Equipment JSC maintains a current ratio of 2.25, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Binh Dinh Pharmaceutical & Medical Equipment JSC recorded 44.78B in income tax expense.

As of the close on October 22, 2026, Binh Dinh Pharmaceutical & Medical Equipment JSC's stock has declined approximately 12.45% over the past 52 weeks. The 50-day moving average sits at 47,322.00, while the 200-day moving average is 49,962.25.

As of June 30, 2026, Binh Dinh Pharmaceutical & Medical Equipment JSC holds 524.74B in cash and equivalents against 257.08B in total debt, resulting in a net debt position of 71.78B. Total book value stands at 1.74T, with working capital of 886.91B providing operational flexibility.

Binh Dinh Pharmaceutical & Medical Equipment JSC produced 373.24B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -416.60B in capital expenditures, free cash flow totaled -43.36B - equivalent to -458.84 per share.

Over the twelve months ended June 30, 2026, Binh Dinh Pharmaceutical & Medical Equipment JSC paid dividends of 6.44 per share. Free cash flow yield is negative at -0.88: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.

Binh Dinh Pharmaceutical & Medical Equipment JSC's most recent stock split took place on June 19, 2024 with a 4:5 split ratio.